Official websites use. Share sensitive information only on official, secure websites. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material.
If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Chronic obstructive pulmonary disease COPD is projected to become the third cause of mortality worldwide. COPD shares several pathophysiological mechanisms with cardiovascular disease, especially atherosclerosis. A total of 15, patients were included in this analysis. Of them, 5. They were more often elderly and with a more pronounced cardiovascular risk profile. No preminent procedural dissimilarities were noticed except for a lower proportion of dual antiplatelet therapy at discharge among COPD patients COPD was associated with significantly higher rates of in-hospital and days mortality.
However, this association disappeared after adjustment for baseline characteristics. Trial registration number: NCT 2nd June Chronic obstructive pulmonary disease COPD has been estimated affecting more than million people worldwide, representing the fourth highest cause of death in the world, with a projection to be the third leading cause of death in next years [ 1 ].
It represents a chronic inflammatory process affecting airways and lung parenchyma leading to an irreversible or partly reversible airflow obstruction [ 2 ]. Main risk factor is constituted by cigarette smoking, that is also crucial in promoting atherosclerosis.
